Literature DB >> 15681471

Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC1).

Hiroyuki Nakamura1, Daisuke Sawamura, Maki Goto, Hideki Nakamura, James R McMillan, Susam Park, Sumio Kono, Shiro Hasegawa, Son'e Paku, Tomohiko Nakamura, Yoshihumi Ogiso, Hiroshi Shimizu.   

Abstract

Epidermolysis bullosa (EB) is an inherited mechano-bullous disorder of the skin, and is divided into three major categories: EB simplex (EBS), dystrophic EB, and junctional EB (JEB). Mutations in the plectin gene (PLEC1) cause EBS associated with muscular dystrophy, whereas JEB associated with pyloric atresia (PA) results from mutations in the alpha6 and beta4 integrin genes. In this study, we examined three EB patients associated with PA from two distinct families. Electron microscopy detected blister formation within the basal keratinocytes leading to the diagnosis of EBS. Surprisingly, immunohistochemical studies using monoclonal antibodies to a range of basement membrane proteins showed that the expression of plectin was absent or markedly attenuated. Sequence analysis demonstrated four novel PLEC1 mutations. One proband was a compound heterozygote for a nonsense mutation of Q305X and a splice-site mutation of 1344G-->A. An exon-trapping experiment suggested that the splice-site mutation induced aberrant splicing of the gene. The second proband harbored a heterozygous maternal nonsense mutation, Q2538X and homozygous nonsense mutations R1189X. Analysis of the intragenic polymorphisms of PLEC1 suggested that R1189X mutations were due to paternal segmental uniparental isodisomy. These results indicate that PLEC1 is a possible causative gene in this clinical subtype, EBS associated with PA. Furthermore, two patients out of our three cases died in infancy. In terms of clinical prognosis, this novel subtype is the lethal variant in the EBS category.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681471      PMCID: PMC1867514          DOI: 10.1016/S1525-1578(10)60005-0

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  40 in total

1.  Congenital pyloric atresia in a newborn with extensive aplasia cutis congenita and epidermolysis bullosa simplex.

Authors:  D S Morrell; D S Rubenstein; R A Briggaman; J D Fine; L Pulkkinen; J Uitto
Journal:  Br J Dermatol       Date:  2000-12       Impact factor: 9.302

2.  Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia.

Authors:  G H Ashton; P Sorelli; J E Mellerio; F M Keane; R A Eady; J A McGrath
Journal:  Br J Dermatol       Date:  2001-02       Impact factor: 9.302

3.  Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization.

Authors:  W H McLean; L Pulkkinen; F J Smith; E L Rugg; E B Lane; F Bullrich; R E Burgeson; S Amano; D L Hudson; K Owaribe; J A McGrath; J R McMillan; R A Eady; I M Leigh; A M Christiano; J Uitto
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

4.  Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex.

Authors:  Marcel F Jonkman; Hendri H Pas; Miranda Nijenhuis; Guus Kloosterhuis; Gerritvander Steege
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

5.  Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice.

Authors:  R van der Neut; P Krimpenfort; J Calafat; C M Niessen; A Sonnenberg
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

6.  Epidermolysis bullosa simplex (Dowling-Meara type) associated with pyloric atresia and congenital urologic abnormalities.

Authors:  D K Kim; S C Kim; S N Chang; S Y Kim
Journal:  Yonsei Med J       Date:  2000-06       Impact factor: 2.759

Review 7.  Complex and segmental uniparental disomy (UPD): review and lessons from rare chromosomal complements.

Authors:  D Kotzot
Journal:  J Med Genet       Date:  2001-08       Impact factor: 6.318

8.  Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice.

Authors:  E Georges-Labouesse; N Messaddeq; G Yehia; L Cadalbert; A Dierich; M Le Meur
Journal:  Nat Genet       Date:  1996-07       Impact factor: 38.330

9.  A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations.

Authors:  Dörte Koss-Harnes; Bjørn Høyheim; Ingrun Anton-Lamprecht; Aud Gjesti; Randi S Jørgensen; Frode L Jahnsen; Bjørnar Olaisen; Gerhard Wiche; Tobias Gedde-Dahl
Journal:  J Invest Dermatol       Date:  2002-01       Impact factor: 8.551

10.  Molecular consequences of deletion of the cytoplasmic domain of bullous pemphigoid 180 in a patient with predominant features of epidermolysis bullosa simplex.

Authors:  Lionel Fontao; Kaisa Tasanen; Marcel Huber; Daniel Hohl; Jan Koster; Leena Bruckner-Tuderman; Arnoud Sonnenberg; Luca Borradori
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

View more
  14 in total

1.  First successful preimplantation genetic diagnosis of epidermolysis bullosa with pyloric atresia: case study of a novel c.4505-4508insACTC mutation.

Authors:  Ayvaz Ozge; Hatırnaz Safak; Hatırnaz Ebru; Unsal Evrim; Sinanoglu Ekin Bilge; Ozer Leyla; Kadı Ali Kemal; Baltacı Volkan
Journal:  J Assist Reprod Genet       Date:  2012-02-22       Impact factor: 3.412

Review 2.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

3.  Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.

Authors:  R Varki; S Sadowski; E Pfendner; J Uitto
Journal:  J Med Genet       Date:  2006-02-10       Impact factor: 6.318

Review 4.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

5.  Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy.

Authors:  Hulya Gundesli; Beril Talim; Petek Korkusuz; Burcu Balci-Hayta; Sebahattin Cirak; Nurten A Akarsu; Haluk Topaloglu; Pervin Dincer
Journal:  Am J Hum Genet       Date:  2010-11-25       Impact factor: 11.025

Review 6.  Epidermolysis bullosa with pyloric atresia.

Authors:  Hye Jin Chung; Jouni Uitto
Journal:  Dermatol Clin       Date:  2010-01       Impact factor: 3.478

7.  A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.

Authors:  Rosa B Thorolfsdottir; Gardar Sveinbjornsson; Patrick Sulem; Anna Helgadottir; Solveig Gretarsdottir; Stefania Benonisdottir; Audur Magnusdottir; Olafur B Davidsson; Sridharan Rajamani; Dan M Roden; Dawood Darbar; Terje R Pedersen; Marc S Sabatine; Ingileif Jonsdottir; David O Arnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Hilma Holm; Kari Stefansson
Journal:  J Am Coll Cardiol       Date:  2017-10-24       Impact factor: 24.094

Review 8.  Plectin-intermediate filament partnership in skin, skeletal muscle, and peripheral nerve.

Authors:  Maria J Castañón; Gernot Walko; Lilli Winter; Gerhard Wiche
Journal:  Histochem Cell Biol       Date:  2013-06-09       Impact factor: 4.304

9.  Plectin deficiency leads to both muscular dystrophy and pyloric atresia in epidermolysis bullosa simplex.

Authors:  Ken Natsuga; Wataru Nishie; Satoru Shinkuma; Ken Arita; Hideki Nakamura; Makiko Ohyama; Hitoshi Osaka; Takeshi Kambara; Yoshiaki Hirako; Hiroshi Shimizu
Journal:  Hum Mutat       Date:  2010-10       Impact factor: 4.878

10.  Cytoplasmic plaque formation in hemidesmosome development is dependent on SoxF transcription factor function.

Authors:  Shelly Oommen; Mathias Francois; Maiko Kawasaki; Melanie Murrell; Katsushige Kawasaki; Thantrira Porntaveetus; Sarah Ghafoor; Neville J Young; Yoshimasa Okamatsu; John McGrath; Peter Koopman; Paul T Sharpe; Atsushi Ohazama
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.